All In Biotech

Drug Trial Radar · NCT05126901

Evaluate the Safety and Efficacy of Ferric Maltol Oral Suspension vs. Ferrous Sulfate Oral Liquid in Children and Adolescents Aged 2 to 17 Years With Iron-deficiency Anaemia, With a Single Arm Study in Infants Aged 1 Month to Less Than 2 Years

Randomised, Open-label, Active-controlled, Multicentre, Comparative Study to Evaluate the Safety and Efficacy of Ferric Maltol (Iron (III)-Maltol Complex) (ST10) Oral Suspension Compared to Ferrous Sulfate Oral Liquid in Children and Adolescents Aged 2 to 17 Years With Iron-deficiency Anaemia, Incorporating a Single Arm Study in Infants Aged 1 Month to Less Than 2 Years

Last checked: Nov 20, 2026Latest source record: Nov 10, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

65

Actual

Start

Nov 3, 2021

Primary completion

Jun 9, 2024

Study completion Jun 9, 2024

Sponsor

Lead sponsor
Shield TherapeuticsIndustry
Sponsor type
Industry
First posted
Nov 19, 2021

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 1 month, up to 17 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The objective of the study is to compare the safety and gastrointestinal tolerability of ferric maltol oral suspension and ferrous sulfate oral liquid in children and adolescents aged 2 years to 17 years, and assess the safety and tolerability of ferric maltol oral suspension in children 1 month to less than 2 years, in the treatment of iron deficiency anaemia during the 12 weeks treatment period.

Conditions

  • Anemia
  • Iron-deficiency

Interventions

  • Ferric MaltolDrug

    Ferric maltol oral suspension: 150 ml amber glass bottle with graduated syringe and adaptor. Oral suspension containing 30 mg elemental iron, in the form of 231.5 mg ferric maltol, in 5 ml suspension Study dosage: The dose of ferric maltol oral suspension that will be administered for children aged 1 month to \< 2 yrs: 0.1 ml/kg BID, 2 to - 11 yrs: 2.5 ml BID, 12-17 yrs: 5 ml BID.

  • Ferrous sulfateDrug

    Ferrous sulfate 125 mg/ml (25 mg/ml elemental iron) oral liquid : 15 ml glass bottle. Study dosage: For ferrous sulfate oral liquid, the dose administered will be for children and adolescents aged 2 years to 17 yrs: 6 mg/kg to the maximum of 4 ml BID.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change in Hemoglobin ConcentrationTime frame: From baseline to week 12.

Locations

23 sites in 3 countries. Site status is shown where the registry gives one.

  • The Center for Clinical Trials

    Saraland, Alabama

  • Homestead Research Institute

    Homestead, Florida

  • Kissimmee Clinical Research Corp

    Kissimmee, Florida

  • Miami Clinical Research

    Miami, Florida

  • Medical Research of Westcheste

    Miami, Florida

  • Eminent Clinical Research and Associates

    North Lauderdale, Florida

  • Clinical Research Prime

    Idaho Falls, Idaho

  • Sierra Clinical Research

    Las Vegas, Nevada

  • Levine Cancer Institute

    Charlotte, North Carolina

  • Penn State Hershey Children's Hospital

    Hershey, Pennsylvania

  • Hasbro Children's Hospital

    Providence, Rhode Island

  • BRCR Global Texas

    Edinburg, Texas

  • Zion Research

    Katy, Texas

  • MultiCare Health System Institute for Research and Innovation

    Tacoma, Washington

  • BRCR Global Puerto

    San Juan, Puerto Rico

  • Noah's Ark Children's Hospital for Wales

    Cardiff, United Kingdom

  • Royal Hospital for Sick Children - Edinburgh

    Edinburgh, United Kingdom

  • Leicester Royal Infirmary

    Leicester, United Kingdom

  • Alder Hey Children's NHS Foundation Trust

    Liverpool, United Kingdom

  • King's College Hospital

    London, United Kingdom

  • Newham University Hospital

    London, United Kingdom

  • Royal Manchester Children's Hospital

    Manchester, United Kingdom

  • Nottingham University Hospitals

    Nottingham, United Kingdom

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.